|
|
Article: Published Data on IL13-PE38 Identifies Mechanism of Drug Action for The Treatment of Malignant Glioma.
- Article from:
- PR Newswire
- Article date:
- November 7, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Intratumoral Administration of IL13-PE38 Induces Apoptotic Cell Death in Human Malignant Glioma Tumor Xenografts
NeoPharm, Inc. announced today new findings for IL13-PE38 reported in the October issue of Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research ( http://mct.aacrjournals.org/ ). The research was conducted under the direction of Dr. Raj Puri and colleagues from the Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), as part of a collaboration between FDA and NeoPharm, Inc. under a Cooperative Research and ...